DNMT1 and neoplasm: Although that the targets of miR-34a repressed the stemness of OSLCs requires further exploration, we here demonstrated that the tumor growth in subcutaneous nude mouse xenograft models of OSLCs was suppressed by treatment with either the DNMT1 inhibitor Aza-dC or agomir-34a.